Thomas Christine E 4
4 · FEMASYS INC · Filed Feb 2, 2024
Insider Transaction Report
Form 4
FEMASYS INCFEMY
Thomas Christine E
Chief Reg & Clinical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+32,600→ 32,600 totalExercise: $0.80Exp: 2034-02-01→ Common Stock (32,600 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option vest equally in installments over 4 years beginning on February 1, 2024, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.